胸腔镜肺癌手术治疗老年非小细胞肺癌的临床效果

Clinical Effect of Thoracoscopic Surgery for Lung Cancer in Elderly Patients with Non-small Cell Lung Cancer

目的本次试验将针对早期非小细胞肺癌患者实施胸腔镜下治疗以及常规开胸肺癌根治术,通过两种手术形式的对比更好为患者提供治疗方案。方法本次试验选取了2017年1月至2018年12月在本院进行治疗的老年患者为对象,经过CT检查和穿刺病理活检得到确诊,针对非小细胞肺癌且符合试验要求的40例患者以单双数的形式分别进行不同方案的治疗。对照组患者采用常规开胸肺癌根治术,观察组患者则使用胸腔镜下肺癌根治术,比较两组患者的治疗效果。结果观察组治疗总有效率为80.00%,明显高于对照组的50.00%(P <0.05)。观察组患者在手术用时、术中出血量、术后总引流量、住院时间、引流管滞留时间、镇痛药用量均短于对照组,差异有统计学意义(P <0.05)。观察组并发症发生率为10.00%(2/20),明显低于对照组的20.00%(4/20),具有统计学意义(P <0.05)。结论采用胸腔镜治疗措施能够更好地改善老年非小细胞肺癌患者的病情,有助于提升治疗总疗效,并发症少,安全性高。

Objective This experiment will be aimed at early non-small cell lung cancer patients with thoracoscopic treatment and conventional thoracotomy lung cancer radical surgery,through the comparison of the two surgical forms,to provide better treatment for patients.Methods In this experiment,elderly patients treated in our hospital from January 2017 to December 2018 were selected as the objects.After CT examination and biopsy,40 patients with nonsmall cell lung cancer who met the experimental requirements were treated with diff erent treatment schemes in the form of single or even number.The control group was treated with conventional thoracotomy lung cancer radical surgery;the observation group was treated with thoracoscopic lung cancer radical surgery,and then the treatment results were discussed.Results The total eff ective rate of treatment in the observation group was 80.00%,which was signifi cantly higher than the 50.00%in the control group(P<0.05).The operation time,intraoperative blood loss,total postoperative drainage,hospitalization time,drainage tube retention time,and analgesic dosage of the observation group were shorter than those of the control group,and the difference was statistically signifi cant(P<0.05).The complication rate of the observation group was 10.00%(2/20),which was signifi cantly lower than the 20.00%(4/20)of the control group,which was statistically signifi cant(P<0.05).Conclusion The use of thoracoscopic treatment can better improve the condition of elderly patients with non-small cell lung cancer,help to improve the overall curative eff ect of the treatment,with fewer complications and high safety.